NCSTN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.763800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.484800E-01
Normal-vs-Stage2
9.517200E-01
Normal-vs-Stage3
3.461000E-01
Normal-vs-Stage4
4.048200E-01
Stage1-vs-Stage2
6.552000E-01
Stage1-vs-Stage3
1.144230E-01
Stage1-vs-Stage4
4.210200E-01
Stage2-vs-Stage3
2.074200E-01
Stage2-vs-Stage4
5.887500E-02
Stage3-vs-Stage4
1.358420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.327400E-01
Normal-vs-AfricanAmerican
7.229600E-01
Normal-vs-Asian
8.058200E-01
Caucasian-vs-AfricanAmerican
6.387800E-01
Caucasian-vs-Asian
4.029400E-01
AfricanAmerican-vs-Asian
8.733600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.739000E-01
Normal-vs-Female
9.181200E-01
Male-vs-Female
6.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.826200E-01
Normal-vs-Age(41-60Yrs)
5.805000E-01
Normal-vs-Age(61-80Yrs)
7.841400E-01
Normal-vs-Age(81-100Yrs)
5.127200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.641600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.008000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.226800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.278700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.225800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.316000E-01
Normal-vs-Daily Drinker
6.496200E-01
Normal-vs-Weekly Drinker
9.537400E-01
Normal-vs-Occasional Drinker
3.541400E-01
Normal-vs-Social Drinker
7.718000E-01
Non Drinker-vs-Daily Drinker
8.653000E-01
Non Drinker-vs-Weekly Drinker
2.645600E-01
Non Drinker-vs-Occasional Drinker
1.699980E-03
Non Drinker-vs-Social Drinker
2.395800E-01
Daily Drinker-vs-Weekly Drinker
4.002400E-01
Daily Drinker-vs-Occasional Drinker
9.557700E-03
Daily Drinker-vs-Social Drinker
4.442200E-01
Weekly Drinker-vs-Occasional Drinker
1.690190E-01
Weekly Drinker-vs-Social Drinker
7.102400E-01
Occasional Drinker-vs-Social Drinker
1.833740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.899900E-02
Normal-vs-Grade 2
4.523400E-03
Normal-vs-Grade 3
6.562100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.540200E-01
Grade 1-vs-Grade 3
3.406600E-01
Grade 1-vs-Grade 4
3.899900E-02
Grade 2-vs-Grade 3
6.448400E-01
Grade 2-vs-Grade 4
4.523400E-03
Grade 3-vs-Grade 4
6.562100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.733600E-01
Normal-vs-NonDiabetic
9.433200E-01
Diabetic-vs-NonDiabetic
7.875600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.667800E-01
Normal-vs-NoPancreatitis
9.465000E-01
Pancreatitis-vs-NoPancreatitis
6.308000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.119000E-01
Normal-vs-N1
8.803000E-01
N0-vs-N1
3.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.208600E-01
Normal-vs-TP53-NonMutant
9.875200E-01
TP53-Mutant-vs-TP53-NonMutant
1.292810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
